Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan F Assmann

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
Blood|September 4, 2015
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infectionThomas H Price, Michael Boeckh, Ryan W Harrison, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
The New England Journal of Medicine|February 19, 2010
Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.
The New England Journal of Medicine|April 9, 2015
Effects of red-cell storage duration on patients undergoing cardiac surgeryMarie E Steiner, Paul M Ness, Susan F Assmann, et al.
The New England Journal of Medicine|November 7, 2022
Surgery or Endovascular Therapy for Chronic Limb-Threatening IschemiaAlik Farber, Matthew T Menard, Michael S Conte, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
Blood|September 4, 2015
Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infectionThomas H Price, Michael Boeckh, Ryan W Harrison, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
The New England Journal of Medicine|February 19, 2010
Dose of prophylactic platelet transfusions and prevention of hemorrhageSherrill J Slichter, Richard M Kaufman, Susan F Assmann, et al.
The New England Journal of Medicine|April 9, 2015
Effects of red-cell storage duration on patients undergoing cardiac surgeryMarie E Steiner, Paul M Ness, Susan F Assmann, et al.
The New England Journal of Medicine|November 7, 2022
Surgery or Endovascular Therapy for Chronic Limb-Threatening IschemiaAlik Farber, Matthew T Menard, Michael S Conte, et al.
Pageof 4